- Latest Updates
FDA authorizes Pfizer’s COVID-19 antiviral pill
The treatment is the first of its kind to be authorized in the U.S. It will be available for adults and children older than 12 who are at risk of severe disease.
What you need to know:
The U.S. Food and Drug Administration has authorized the emergency use of Pfizer’s antiviral pill for adults and children older than 12 who have tested positive for COVID-19 and are at high risk of severe disease. The drug—which has been shown to reduce the risk of hospitalization and death—is the first of its kind to be approved for use in the United States.
It’s unclear how effective the drug will be against the new Omicron variant. But health officials hailed the FDA authorization as one more tool available to doctors and patients who are fighting the disease.
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally—a major step forward